Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Watts

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Annals (Royal College of Physicians and Surgeons of Canada)|August 1, 1992
Teaching of biomedical ethics in postgraduate training programsJean Desjardins, Nuala P Kenny, Abbyann Lynch, et al.
Bioorganic & Medicinal Chemistry|January 18, 2005
Synthesis and evaluation of cis-hexahydropyrrolo[3,2-b]pyrrol-3-one peptidomimetic inhibitors of CAC1 cysteinyl proteinasesMartin Quibell, Alex Benn, Nick Flinn, et al.
Bioorganic & Medicinal Chemistry|May 15, 2004
Functionalised 2,3-dimethyl-3-aminotetrahydrofuran-4-one and N-(3-oxo-hexahydrocyclopenta[b]furan-3a-yl)acylamide based scaffolds: synthesis and cysteinyl proteinase inhibitionJohn Watts, Alex Benn, Nick Flinn, et al.
Women'S Health Reports (New Rochelle, N.Y.)|October 27, 2025
Update on Trends in Placenta Accreta Syndrome and Its Impact on Maternal-Fetal Morbidity in the United StatesMulubrhan F Mogos, Tara Maxa, John Watts, et al.
Journal of Biomedical Nanotechnology|June 15, 2019
Development of the iCubate Molecular Diagnostic Platform Utilizing Amplicon Rescue Multiplex Polymerase Chain ReactionHongna Liu, Kathryn Heflin, Jian Han, et al.
BMJ Open|July 19, 2017
A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study protocolDavid Currow, Gareth John Watts, Miriam Johnson, et al.
Heart, Lung & Circulation|May 18, 2026
Improving End-of-Life Care for Patients in Australian Cardiology Wards: A Retrospective Medical Record AuditTessa Holman, Peter Macdonald, Diana Slade, et al.
Cancer Cell|August 22, 2025
Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potencyAlexander Biederstädt, Rafet Basar, Jeong-Min Park, et al.
Journal of Medicinal Chemistry|August 13, 2021
Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2Tom D Heightman, Valerio Berdini, Luke Bevan, et al.
Journal of Medicinal Chemistry|May 19, 2018
Fragment-Based Discovery of a Potent, Orally Bioavailable Inhibitor That Modulates the Phosphorylation and Catalytic Activity of ERK1/2Tom D Heightman, Valerio Berdini, Hannah Braithwaite, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Annals (Royal College of Physicians and Surgeons of Canada)|August 1, 1992
Teaching of biomedical ethics in postgraduate training programsJean Desjardins, Nuala P Kenny, Abbyann Lynch, et al.
Bioorganic & Medicinal Chemistry|January 18, 2005
Synthesis and evaluation of cis-hexahydropyrrolo[3,2-b]pyrrol-3-one peptidomimetic inhibitors of CAC1 cysteinyl proteinasesMartin Quibell, Alex Benn, Nick Flinn, et al.
Bioorganic & Medicinal Chemistry|May 15, 2004
Functionalised 2,3-dimethyl-3-aminotetrahydrofuran-4-one and N-(3-oxo-hexahydrocyclopenta[b]furan-3a-yl)acylamide based scaffolds: synthesis and cysteinyl proteinase inhibitionJohn Watts, Alex Benn, Nick Flinn, et al.
Women'S Health Reports (New Rochelle, N.Y.)|October 27, 2025
Update on Trends in Placenta Accreta Syndrome and Its Impact on Maternal-Fetal Morbidity in the United StatesMulubrhan F Mogos, Tara Maxa, John Watts, et al.
Journal of Biomedical Nanotechnology|June 15, 2019
Development of the iCubate Molecular Diagnostic Platform Utilizing Amplicon Rescue Multiplex Polymerase Chain ReactionHongna Liu, Kathryn Heflin, Jian Han, et al.
BMJ Open|July 19, 2017
A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study protocolDavid Currow, Gareth John Watts, Miriam Johnson, et al.
Heart, Lung & Circulation|May 18, 2026
Improving End-of-Life Care for Patients in Australian Cardiology Wards: A Retrospective Medical Record AuditTessa Holman, Peter Macdonald, Diana Slade, et al.
Cancer Cell|August 22, 2025
Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potencyAlexander Biederstädt, Rafet Basar, Jeong-Min Park, et al.
Journal of Medicinal Chemistry|August 13, 2021
Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2Tom D Heightman, Valerio Berdini, Luke Bevan, et al.
Journal of Medicinal Chemistry|May 19, 2018
Fragment-Based Discovery of a Potent, Orally Bioavailable Inhibitor That Modulates the Phosphorylation and Catalytic Activity of ERK1/2Tom D Heightman, Valerio Berdini, Hannah Braithwaite, et al.
Pageof 3